New selective COMT inhibitors: useful adjuncts for Parkinson's disease?
- 1 February 1989
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 10 (2) , 54-56
- https://doi.org/10.1016/0165-6147(89)90075-8
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Catechol-O-methyltransferase activity in human and rat small intestineLife Sciences, 1988
- Clinical Pharmacokinetics of Anti-Parkinsonian DrugsClinical Pharmacokinetics, 1987
- Pharmacokinetics of LevodopaClinical Neuropharmacology, 1984
- 3‐O‐Methyldopa inhibits rotations induced by levodopa in rats after unilateral destruction of the nigrostriatal pathwayNeurology, 1982
- Catechol-O-methyltransferase activity: A determinant of levodopa responseClinical Pharmacology & Therapeutics, 1980
- The Clinical Picture and Plasma Levodopa Metabolite Profile of Parkinsonian NonrespondersArchives of Neurology, 1977
- “On‐off” phenomenon with levodopa therapy in parkinsonismNeurology, 1974
- Parkinsonism treated with 3‐0‐methyldopaClinical Pharmacology & Therapeutics, 1973
- Effect of chronic administration of L-dopa on catechol-O-methyltransferase in rat tissuesLife Sciences, 1973
- The metabolism of L‐3–0‐methyldopa, aprecursor of dopa in manClinical Pharmacology & Therapeutics, 1971